Suppr超能文献

人 EndoC-βH1 细胞中干扰素信号的时间调节。

Temporal regulation of interferon signalling in human EndoC-βH1 cells.

机构信息

Islet Biology Group (IBEx), Exeter Centre of Excellence in Diabetes (EXCEED), Institute of Biomedical & Clinical Science, University of Exeter Medical School, Exeter, UK.

出版信息

J Mol Endocrinol. 2022 May 19;69(2):299-313. doi: 10.1530/JME-21-0224.

Abstract

During the development of type 1 diabetes, interferons (IFN) are elaborated from islet-infiltrating immune cells and/or from virally infected β-cells. They act via specific receptors to increase, acutely, the phosphorylation of the transcription factors STAT1 and 2. However, the longer-term impacts of chronic IFN stimulation are poorly understood and were investigated in the current study. Human EndoC-βH1 cells were treated with IFNα, IFNγ or IFNλ either acutely (<2 h) or chronically (≥24 h) and STAT phosphorylation, expression and activity were assessed by Western blotting and transcriptional reporter assays. Exposure of β-cells to IFNα or IFNλ induced a swift increase in the phosphorylation of both STAT1 and STAT2, whereas IFNγ increased only pSTAT1. Over more extended periods (≥24 h), STAT phosphorylation declined but STAT1 and STAT2 expression were enhanced in a sustained manner. All IFNs stimulated ISRE transcriptional activity (but with different time courses), whereas GAS activity was responsive only to IFNγ. The re-addition of a second bolus of IFNα, 24 h after an initial dose, failed to cause renewed STAT1/2 phosphorylation. By contrast, when IFNγ was added 24 h after exposure to IFNα, rapid STAT1 phosphorylation was re-initiated. Exposure of β-cells to IFNs leads to rapid, transient, STAT phosphorylation and to slower and more sustained increases in total STAT1/2 levels. The initial phosphorylation response is accompanied by marked desensitisation to the cognate agonist. Together, the results reveal that the response of β-cells to IFNs is regulated both temporally and quantitatively to achieve effective signal integration.

摘要

在 1 型糖尿病的发展过程中,干扰素 (IFN) 由胰岛浸润的免疫细胞和/或病毒感染的 β 细胞产生。它们通过特异性受体作用,急性增加转录因子 STAT1 和 STAT2 的磷酸化。然而,慢性 IFN 刺激的长期影响知之甚少,本研究对此进行了探讨。人 EndoC-βH1 细胞用 IFNα、IFNγ 或 IFNλ 急性(<2 h)或慢性(≥24 h)处理,通过 Western blot 和转录报告基因检测评估 STAT 磷酸化、表达和活性。β 细胞暴露于 IFNα 或 IFNλ 会迅速增加 STAT1 和 STAT2 的磷酸化,而 IFNγ 仅增加 pSTAT1。在更长的时间(≥24 h)内,STAT 磷酸化下降,但 STAT1 和 STAT2 的表达持续增强。所有 IFNs 均刺激 ISRE 转录活性(但时间进程不同),而 GAS 活性仅对 IFNγ 有反应。在初始剂量 24 小时后再次加入第二剂量 IFNα 未能引起 STAT1/2 的再次磷酸化。相比之下,当 IFNγ 在暴露于 IFNα 24 小时后加入时,快速的 STAT1 磷酸化被重新启动。IFN 暴露导致 β 细胞快速、短暂的 STAT 磷酸化,并导致总 STAT1/2 水平的缓慢和更持续增加。初始磷酸化反应伴随着对同源激动剂的明显脱敏。总之,这些结果表明,β 细胞对 IFNs 的反应受到时间和数量的调节,以实现有效的信号整合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b12/9175560/279b00a32390/JME-21-0224fig1.jpg

相似文献

1
Temporal regulation of interferon signalling in human EndoC-βH1 cells.
J Mol Endocrinol. 2022 May 19;69(2):299-313. doi: 10.1530/JME-21-0224.
4
Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation.
J Biol Chem. 2004 Mar 26;279(13):12379-85. doi: 10.1074/jbc.M310787200. Epub 2004 Jan 13.
5
STAT1 modification improves therapeutic effects of interferons on lung cancer cells.
J Transl Med. 2015 Sep 8;13:293. doi: 10.1186/s12967-015-0656-0.
6
Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.
Front Immunol. 2023 Oct 3;14:1263926. doi: 10.3389/fimmu.2023.1263926. eCollection 2023.
8
Marburg virus evades interferon responses by a mechanism distinct from ebola virus.
PLoS Pathog. 2010 Jan 15;6(1):e1000721. doi: 10.1371/journal.ppat.1000721.
10
IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.
Cancer Biol Ther. 2008 Jul;7(7):1109-15. doi: 10.4161/cbt.7.7.6192. Epub 2008 Apr 24.

引用本文的文献

1
The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes.
Front Endocrinol (Lausanne). 2023 Oct 6;14:1270325. doi: 10.3389/fendo.2023.1270325. eCollection 2023.
2
Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.
Front Immunol. 2023 Oct 3;14:1263926. doi: 10.3389/fimmu.2023.1263926. eCollection 2023.

本文引用的文献

1
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes.
Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1;28(4):397-403. doi: 10.1097/MED.0000000000000646.
2
Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes.
Int Rev Cell Mol Biol. 2021;359:1-80. doi: 10.1016/bs.ircmb.2021.02.011. Epub 2021 Mar 23.
3
Footprints of Immune Cells in the Pancreas in Type 1 Diabetes; to "B" or Not to "B": Is That Still the Question?
Front Endocrinol (Lausanne). 2021 Feb 25;12:617437. doi: 10.3389/fendo.2021.617437. eCollection 2021.
4
New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes.
Front Endocrinol (Lausanne). 2021 Jan 5;11:606434. doi: 10.3389/fendo.2020.606434. eCollection 2020.
5
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.
Front Immunol. 2020 Nov 23;11:606456. doi: 10.3389/fimmu.2020.606456. eCollection 2020.
7
Type 1 Diabetes: Interferons and the Aftermath of Pancreatic Beta-Cell Enteroviral Infection.
Microorganisms. 2020 Sep 15;8(9):1419. doi: 10.3390/microorganisms8091419.
10
What the HLA-I!-Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes.
Curr Diab Rep. 2019 Dec 9;19(12):159. doi: 10.1007/s11892-019-1245-z.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验